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Cognitive testing for dementia is adversely
affected by administration in a foreign location
Cynthia Bechtel1, Ruth Remington1, Bruce Barton2, Constance Barasauskas2 and Thomas B Shea3*
Abstract
Background: It is colloquially considered that cognitive tests can be adversely affected by administration in a
foreign location. However, a definitive demonstration of this is lacking in the literature. To determine whether or
not this is the case, we compared the results of cognitive testing in a familiar versus foreign environment by single test
administrator of individuals diagnosed with Alzheimer’s disease randomized to placebo in a multi-site clinical study.
Findings: Cognitive tests were administered to 6 long-term residents of an assisted living facility at their residence
(the “Familiar” cohort). The identical tests were administered to a newly admitted resident and to 2 community-dwelling
individuals who drove to the administrator’s office for the first time (the “Foreign” cohort). Secondary testing was
administered 3 months later at the same respective locations. Caregivers of participants completed reports of mood,
behavior and activities of daily living.
The Familiar cohort performed equally well at both visits. The Foreign cohort performed significantly worse than the
Familiar cohort at baseline. They improved statistically, and matched Familiar cohort performance, by their second visit.
Caregiver reports for both cohorts were unchanged between visits.
Conclusions: These findings support the notion that a foreign location can adversely affect performance on cognitive
tests, and therefore support cognitive testing in a familiar location.
Keywords: Alzheimer’s disease, Cognitive testing, Orientation, Clinical trial
Findings
Rationale
Cognitive impairment in Alzheimer’s disease encompasses
disorientation, disorder confusion, and impairments in
perception that can contribute to agitation [1-4]. In
this regard, it is colloquially considered that cognitive
screening and evaluation can be adversely affected by
multiple distractors, among which is the administration of
cognitive tests in a foreign location. However, we note that
the literature is lacking in controlled analyses justifying
whether or not this is the case. Towards this end, we
herein present evidence demonstrating that conducting
cognitive tests in an unfamiliar location can indeed
adversely affect participant performance.
Methods
These data were obtained by a single test administrator
from one site of a multi-site clinical study for a nutritional
intervention for Mild Cognitive Impairment and
Alzheimer’s disease (ClinicalTrials.gov NCT01320527) [5].
The protocol was in compliance with the Helsinki
Declaration and was approved by the New England
IRB (Newton, MA). Signed consent forms were obtained
from the participant and/or health-care proxy. Participants
completed a test battery consisting of the Mini-mental State
Exam (MMSE) [6,7], the Geriatric Depression Scale (GDS)
[8,9], the Royal clock-drawing test (Clox 1 and Clox 2) [10],
and the Dementia Rating Scale version II (DRS) [11-13].
Clock drawings were independently scored by two of us,
with 100% inter-rater reliability. DRS scores as reported
were adjusted for participant age and education (Age
and Education Corrected Moan’s Scaled Score, or
“AEMSS”; according to the DRS reference manual;
www.psychassessments.com). Caregivers completed the
Alzheimer’s disease Cooperative Society–Activities of Daily
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Living (ADCS-ADL) [14] and the Neuropsychiatric
Inventory (NPI) [15] during the same test period.
These tests were administered to 6 long-term residents
of an assisted living facility at their residential location.
Tests were also administered to an additional resident in
the same facility by this same test administrator; however,
this testing session was held on the day after this participant
was admitted to the facility. Two community-dwelling
participants and their caregivers drove to the test
administrator’s office for completion of the test battery.
The 6 long-term residents are hereafter referred to as the
“Familiar” cohort with reference to the familiarity of
their surroundings during initial test administration; the
newly-arrived resident and the 2 community-dwelling are
referred to as the “Foreign” cohort with reference to the
unfamiliarity of their surroundings during the initial test
administration. Three months later, a second round of tests
were administered in the same respective location as the
first; the MMSE and GDS were intended for participant
demographics and were completed only during the first
testing session.
All participants had been randomized to placebo and
therefore there was no direct intervention other than the
potential placebo effect itself, which was in place for all
of these participants. Their status as placebo recipients
was determined only following code breaking according
to trial protocol, which was subsequent to both visits as
described above.
Because of the small sample size, we used a non-
parametric technique (i.e., Wilcoxon rank sum test) to
compare the groups for baseline age, education, MMSE,
and GDS as well as for the outcomes in Figure 1. For
clarity, we presented the mean and standard deviation in
Table 1 and standard box plots in Figure 1.
No significant differences were noted in years of
education and baseline MMSE scores between the Familiar
and Foreign cohorts (Table 1). A trend towards significance
was observed in average age; the average age of the Foreign
Figure 1 Differential performance of foreign and familiar cohorts on the test battery. Panels present representative Clox 1 images for
Foreign and Familiar cohorts from the baseline and 3-month sessions as indicated. The respective scores out of the maximum possible 15 are
indicated in the bottom left of each image. The accompanying graphs present the total scores both cohorts on the test battery; the boxes
represent the 25th and 75th percentile (lower and upper ends, respectively), the line depicts the median, the diamond depicts the mean, and the
whiskers represent the lowest and highest values that are not outliers. See text for further discussion.
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cohort was 5 years younger than the Familiar cohort.
However, the Foreign cohort displayed a significantly
lower mean score on the GDS than did the Familiar
cohort (Table 1).
Results
At their initial session, the Foreign cohort demonstrated
inferior performance (mean score of 2.0) as compared to
that the Familiar cohort (mean score of 5.0) on Clox 1
(in which participants are asked to draw a clock that
displays a specific time, with no clock to copy). Both cohorts
performed equally well at the 3-month session (each
with a mean score of 9.0; Figure 1). The change in
performance of these cohorts between the baseline
and 3-month test session differed statistically (p < 0.04;
nonparametric Wilcoxon test). Performance of the Familiar
cohort did not change between the baseline and 3 month
session. The Foreign cohort did not display any corre-
sponding impairment in performance on Clox 2 (which
only requires copying an existing clock) nor any difference
compared to the performance of the Familiar cohort on
this test (Figure 1). The Foreign cohort did not display any
corresponding impairment in performance on Clox 2
(which only requires copying an existing clock) nor any
difference compared to the performance of the Familiar
cohort on this test (Figure 1). The Foreign cohort
displayed a doubling in scoring on the DRS between the
initial and the 3-month session, while the Familiar cohort
did not display any change in performance (Figure 1).
Caregivers reported no change in the ACDS-ADL and the
NPI (Figure 1).
Performance of the Familiar cohort on CLOX-1 was
identical to that of the overall placebo group in the study
from which these individuals were derived [5] both at
baseline and after 3 months; the overall placebo group
scored 7 ± 5 at baseline, and 7 ± 4 after 3 months; by
contrast, the Foreign cohort scored over 2-fold lower
than this overall placebo group at baseline, but scored
identically to the overall placebo group after 3 months
(Figure 1).
Examination of key portions of GDS and MMSE also
supported the notion that an unfamiliar test location can
adversely influence test performance. The Familiar and
Foreign cohorts displayed identical scores (4.3 ± 0.3 and
4.3 ± 0.8, respectively, mean ± standard error of the mean)
in response to questions on the MMSE regarding orienta-
tion, which have the potential to be adversely affected by
testing in a novel location [16]. In addition, all 3 individuals
of the Foreign cohort responded “no” to the GDS question,
“Do you prefer to stay at home, rather than going out
and doing new things?” By contrast, the majority (4/6)
individuals in the Familiar cohort responded “yes” to this
question. The observation that the Foreign cohort did not
harbor a distinct lack of orientation or a unique adversity
to traveling to a novel location further indicates that the
novel location of baseline testing exerted an acute adverse
effect on their cognitive performance.
Discussion and conclusions
In the absence of any intervention, the significantly-
improved performance of the Foreign cohort at their second
session, coupled with the lack of change in the Familiar
cohort, suggests that the performance of the Foreign cohort
was adversely affected by the initial unfamiliarity of the test
location. In support of this notion, the Foreign cohort did
not display any corresponding impairment in performance
on Clox 2 (which only requires copying an existing clock)
nor any difference compared to the performance of the
Familiar cohort on this test (Figure 1).
Further support was derived from caregivers, who re-
ported no change in the ACDS-ADL and NPI (each of
which reflect day-to-day performance at the individuals’
residence and are therefore independent of test location).
Moreover, caregivers indicated that the Foreign cohort
displayed an average statistically superior performance
in the ACDS-ADL versus the Familiar cohort (p < 0.04
for both test sessions). This is perhaps to be expected
since two individuals of the Foreign cohort were still
community-dwelling and the third had just been admitted
to the assisted living facility, while all members of the
Familiar cohort were established residents of the assisted
living facility; Nevertheless, superior performance of
the Foreign versus Familiar group on the ADCS-ADL
is consistent with conclusion that the lower cognitive
performance of the Foreign cohort scores at the baseline
visit was a result of conducting these tests in an unfamiliar
location.
The limited findings presented herein with this small
cohort of participants provide evidence supporting the
need for a consist location for administration of cognitive
testing, and suggests that failure to do so may increase the
likelihood of aberrant scores, which could artifactually
lower the mean performance of their cohort. The use of a
small sample size imposition a major limitation on inter-
pretation of our findings. However, we note that these
findings were serendipitous, and, furthermore, we are
unable to find any comparable report in the literature. We
therefore consider the presentation of these findings
Table 1 Demographics of participant cohorts
Familiar Foreign p value
Age 87.5 ± 2.6 82.3 ± 5.8 0.22
Education 11.8 ± 0.4 12.3 ± 0.6 0.28
MMSE 18.7 ± 3.7 20.7 ± 4.7 0.76
GDS 3.7 ± 1.0 0.0 ± 0.0 0.03
Values represent the mean ± standard deviation. P values were determined
between the Familiar and Foreign cohorts using a nonparametric
Wilcoxon test.
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important to carry the notion of avoiding a foreign loca-
tion beyond colloquial considerations. The use of the
same administrator in the second round of testing may
also have contributed to increased familiarity and
therefore improvement in scores. Another limitation,
somewhat related to our small test population, is the
difference (although not statistically significant) in age
ranges of our two cohorts (Table 1).
Since even simple disruptions in routine can confound
individuals with dementia, including even carrying out
cognitive testing at different times during the day [17], it
is not surprising that testing in a novel location may
adversely influence test results. These findings address an
inherent difficulty in clinical studies of early dementia,
where a substantially greater number of participants are
likely to be community-dwelling, while those in later
stages are more likely to reside in assisted living facilities
or nursing homes. Cognitive testing of residents of
nursing homes/assisted living facilities is more likely
to be perceived as relatively routine, since residents
commonly encounter facility staff within their resi-
dence. By contrast, cognitive testing of community-
dwelling individuals poses the inherent difficulty of
requiring either a home visitation, which may seem
invasive to the participant as well as the caregiver,
and may prompt or necessitate traveling to a novel
location for test administration. Notably, since our
Foreign cohort displayed significantly improved perform-
ance at the second testing session, which represented only
the second time that the 2 community-dwelling partici-
pants had travelled to this location, we note that one or two
visits to the planned testing location, with either no testing
or perhaps a simple introductory session, may be useful to
reduce the potential adverse influence of a foreign location
on cognitive evaluation. Similarly, our test administrator
was unfortunately not made aware that the resident
of the assisted living facility in our Foreign cohort
had been admitted the previous day; the significantly
improved performance of this individual on the second
testing session clearly indicates that newly-admitted
individuals should be allowed an orientation period
prior to cognitive evaluation to gain familiarity with
the novel residence.
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